1980
DOI: 10.1001/archsurg.1980.01380040043007
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Bone Scan in Preoperative Clinical Staging of Breast Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
1
1
1

Year Published

1984
1984
1998
1998

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(5 citation statements)
references
References 9 publications
2
1
1
1
Order By: Relevance
“…In agreement with other authors (3,12,14,17,21) we found a low specificity (87.7%). Considering the very small number of true positive scans and the low specificity of the test we do not regard bone scanning as a useful test for routine screening of stage 1-11 breast cancer.…”
Section: Discussionsupporting
confidence: 93%
See 3 more Smart Citations
“…In agreement with other authors (3,12,14,17,21) we found a low specificity (87.7%). Considering the very small number of true positive scans and the low specificity of the test we do not regard bone scanning as a useful test for routine screening of stage 1-11 breast cancer.…”
Section: Discussionsupporting
confidence: 93%
“…In the present material there was no statistically significant difference between the prevalence of positive scans in women with or without axillary node involvement in agreement with some reports (8, 9) but in disagreement with others (11, 15). The prevalence was higher in postmenopausal patients than in premenopausal ones as previously reported by some authors (3,8,21). This can be explained by frequent pathologic conditions in older age, which cause increased tracer uptake.…”
Section: Discussionsupporting
confidence: 69%
See 2 more Smart Citations
“…Enfatizam que, assim, evitariam a mastectomia nas pacientes com M, situação em que essa opção terapêutica é menos indicada como forma curativa. Outros autores questionam e não realizam esse rastreio na ausência de sintomatologia sugestiva de doença sistêmica ou no Ec I e II 1,3,5,6,8,20,21 . Adotam essa conduta pois a freqüência de M identificadas nesses estádios é pequena, não justificando seu rastreio indiscriminado em função dos custos elevados.…”
Section: Resultados: O Rastreio De Câncer Bilateral Sincrônico Foi Neunclassified